{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:31:15Z","timestamp":1792042275768,"version":"4.4.0"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["P01 HL-051952"],"award-info":[{"award-number":["P01 HL-051952"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 HL-051952"],"award-info":[{"award-number":["P01 HL-051952"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.mce.2020.111119","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T05:13:54Z","timestamp":1607577234000},"page":"111119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["The Angiotensin-(1\u201312)\/Chymase axis as an alternate component of the tissue renin angiotensin system"],"prefix":"10.1016","volume":"529","author":[{"given":"Carlos M.","family":"Ferrario","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Groban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che Ping","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L","family":"VonCannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendra N.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6720-0101","authenticated-orcid":false,"given":"Xuming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarfaraz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2020.111119_bib1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.peptides.2012.09.016","article-title":"Subcellular characteristics of functional intracellular renin-angiotensin systems","volume":"38","author":"Abadir","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.mce.2020.111119_bib2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/13543776.2018.1531848","article-title":"Chymase inhibitors for the treatment of cardiac diseases: a patent review (2010-2018)","volume":"28","author":"Ahmad","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.mce.2020.111119_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028501","article-title":"Chymase-dependent generation of angiotensin II from angiotensin-(1-12) in human atrial tissue","volume":"6","author":"Ahmad","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.mce.2020.111119_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015759","article-title":"Uptake and metabolism of the novel peptide angiotensin-(1-12) by neonatal cardiac myocytes","volume":"6","author":"Ahmad","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.mce.2020.111119_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jash.2012.12.003","article-title":"Chymase mediates angiotensin-(1-12) metabolism in normal human hearts","volume":"7","author":"Ahmad","year":"2013","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.mce.2020.111119_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11906-014-0429-9","article-title":"Angiotensin-(1-12): a chymase-mediated cellular angiotensin II substrate","volume":"16","author":"Ahmad","year":"2014","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.mce.2020.111119_bib7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.bbrc.2016.07.100","article-title":"Primacy of cardiac chymase over angiotensin converting enzyme as an angiotensin-(1-12) metabolizing enzyme","volume":"478","author":"Ahmad","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2020.111119_bib8","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1113\/EP087209","article-title":"Effects of the selective chymase inhibitor TEI-F00806 on the intrarenal renin-angiotensin system in salt-treated angiotensin I-infused hypertensive mice","volume":"103","author":"Ansary","year":"2018","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.mce.2020.111119_bib9","doi-asserted-by":"crossref","first-page":"C995","DOI":"10.1152\/ajpcell.00238.2006","article-title":"Intracellular angiotensin II induces cell proliferation independent of AT1 receptor","volume":"291","author":"Baker","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.mce.2020.111119_bib10","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/01.RES.88.3.298","article-title":"Canine ventricular myocytes possess a renin-angiotensin system that is upregulated with heart failure","volume":"88","author":"Barlucchi","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.mce.2020.111119_bib11","doi-asserted-by":"crossref","unstructured":"Bone marrow, thymus and blood: changes across the lifespan, Aging Health. 5, 385-393 DOI: 10.2217\/ahe.09.31.","DOI":"10.2217\/ahe.09.31"},{"key":"10.1016\/j.mce.2020.111119_bib12","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1161\/CIRCULATIONAHA.117.029589","article-title":"Increased inflammation in pericardial fluid persists 48 hours after cardiac surgery","volume":"136","author":"Butts","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2020.111119_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacbts.2019.11.006","article-title":"Reduced left atrial emptying fraction and chymase activation in pathophysiology of primary mitral regurgitation","volume":"5","author":"Butts","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.mce.2020.111119_bib14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/hy0202.103441","article-title":"Angiotensinogen and its cleaved derivatives inhibit angiogenesis","volume":"39","author":"Celerier","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2020.111119_bib15","first-page":"149","article-title":"Biphasic changes in thymus structure during evolving renal hypertension","volume":"55","author":"Chatelain","year":"1978","journal-title":"Clin. Sci. Mol. Med."},{"key":"10.1016\/j.mce.2020.111119_bib16","first-page":"737","article-title":"Lymphoid alterations and impaired T lymphocyte reactivity in experimental renal hypertension","volume":"95","author":"Chatelain","year":"1980","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.mce.2020.111119_bib17","article-title":"Hyperglycemia activates the renin-angiotensin system and induces epithelial-mesenchymal transition in streptozotocin-induced diabetic kidneys","volume":"19","author":"Chen","year":"2018","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"key":"10.1016\/j.mce.2020.111119_bib18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/ajh\/2.5.403","article-title":"Regulation of angiotensinogen gene","volume":"2","author":"Clauser","year":"1989","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.mce.2020.111119_bib19","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/HYPERTENSIONAHA.110.155895","article-title":"Aging and the renin-angiotensin system","volume":"60","author":"Conti","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2020.111119_bib20","first-page":"662","article-title":"Molecular genetics of human hypertension: role of angiotensinogen","volume":"18","author":"Corvol","year":"1997","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.mce.2020.111119_bib21","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1161\/01.HYP.33.6.1324","article-title":"Seven lessons from two candidate genes in human essential hypertension: angiotensinogen and epithelial sodium channel","volume":"33","author":"Corvol","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2020.111119_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11906-003-0072-3","article-title":"Inhibition of angiogenesis: a new function for angiotensinogen and des(angiotensin I)angiotensinogen","volume":"5","author":"Corvol","year":"2003","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.mce.2020.111119_bib23","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1258\/ebm.2012.011356","article-title":"Role of chymase in diabetic nephropathy","volume":"237","author":"Cristovam","year":"2012","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.mce.2020.111119_bib24","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/01.HYP.32.6.976","article-title":"Intracellular angiotensin II regulates the inward calcium current in cardiac myocytes","volume":"32","author":"De Mello","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2020.111119_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11010-016-2801-3","article-title":"Intracellular angiotensin-(1-12) changes the electrical properties of intact cardiac muscle","volume":"422","author":"De Mello","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.mce.2020.111119_bib26","doi-asserted-by":"crossref","first-page":"10327","DOI":"10.1038\/s41598-018-28593-6","article-title":"Role of the renin angiotensin system in blood pressure allostasis-induced by severe food restriction in female fischer rats","volume":"8","author":"de Souza","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mce.2020.111119_bib27","first-page":"H2065","article-title":"Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation","volume":"269","author":"Dell'Italia","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.mce.2020.111119_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI119529","article-title":"Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces","volume":"100","author":"Dell'Italia","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mce.2020.111119_bib29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/CIRCRESAHA.117.310978","article-title":"Multifunctional role of chymase in acute and chronic tissue injury and remodeling","volume":"122","author":"Dell'Italia","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.mce.2020.111119_bib30","doi-asserted-by":"crossref","first-page":"H1987","DOI":"10.1152\/ajpheart.00721.2014","article-title":"Depressor effect of chymase inhibitor in mice with high salt-induced moderate hypertension","volume":"309","author":"Devarajan","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.mce.2020.111119_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ahj.2020.01.012","article-title":"Effects of the chymase inhibitor fulacimstat on adverse cardiac remodeling after acute myocardial infarction-Results of the Chymase Inhibitor in Adverse Remodeling after Myocardial Infarction (CHIARA MIA) 2 trial","volume":"224","author":"Duengen","year":"2020","journal-title":"Am. Heart J."},{"key":"10.1016\/j.mce.2020.111119_bib32","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/cpdd.633","article-title":"Safety and tolerability of the chymase inhibitor fulacimstat in patients with left ventricular dysfunction after myocardial infarction-results of the CHIARA MIA 1 trial","volume":"8","author":"Dungen","year":"2019","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.mce.2020.111119_bib33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/1753944716644131","article-title":"Mega clinical trials which have shaped the RAS intervention clinical practice","volume":"10","author":"Dusing","year":"2016","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.mce.2020.111119_bib34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/HYPERTENSIONAHA.109.145839","article-title":"New physiological concepts of the renin-angiotensin system from the investigation of precursors and products of angiotensin I metabolism","volume":"55","author":"Ferrario","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2020.111119_bib35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/1753944716642677","article-title":"Cardiac remodelling and RAS inhibition","volume":"10","author":"Ferrario","year":"2016","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.mce.2020.111119_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.phrs.2017.05.020","article-title":"Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease","volume":"125","author":"Ferrario","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.mce.2020.111119_bib37","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2020.111119_bib38","doi-asserted-by":"crossref","first-page":"H1184","DOI":"10.1152\/ajpheart.01114.2008","article-title":"Differential regulation of angiotensin-(1-12) in plasma and cardiac tissue in response to bilateral nephrectomy","volume":"296","author":"Ferrario","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.mce.2020.111119_bib39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1054-3589(10)59007-0","article-title":"Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7)","volume":"59","author":"Ferrario","year":"2010","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.mce.2020.111119_bib40","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1042\/CS20130400","article-title":"An evolving story of angiotensin-II-forming pathways in rodents and humans","volume":"126","author":"Ferrario","year":"2014","journal-title":"Clin. Sci."},{"key":"10.1016\/j.mce.2020.111119_bib41","doi-asserted-by":"crossref","first-page":"H404","DOI":"10.1152\/ajpheart.00219.2016","article-title":"Intracrine angiotensin II functions originate from noncanonical pathways in the human heart","volume":"311","author":"Ferrario","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.mce.2020.111119_bib42","doi-asserted-by":"crossref","first-page":"H995","DOI":"10.1152\/ajpheart.00833.2015","article-title":"Cardiac angiotensin-(1-12) expression and systemic hypertension in rats expressing the human angiotensinogen gene","volume":"310","author":"Ferrario","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.mce.2020.111119_bib43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fcvm.2019.00163","article-title":"Activation of the human angiotensin-(1-12)-chymase pathway in rats with human angiotensinogen gene transcripts","volume":"6","author":"Ferrario","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.mce.2020.111119_bib44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/gerona\/61.1.28","article-title":"Growth hormone replacement attenuates diastolic dysfunction and cardiac angiotensin II expression in senescent rats","volume":"61","author":"Groban","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.mce.2020.111119_bib45","doi-asserted-by":"crossref","first-page":"R518","DOI":"10.1152\/ajpregu.00525.2011","article-title":"Novel roles of nuclear angiotensin receptors and signaling mechanisms","volume":"302","author":"Gwathmey","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.mce.2020.111119_bib46","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/01.RES.66.4.891","article-title":"Angiotensins and the failing heart. Enhanced positive inotropic response to angiotensin I in cardiomyopathic hamster heart in the presence of captopril","volume":"66","author":"Hirakata","year":"1990","journal-title":"Circ. Res."},{"key":"10.1016\/j.mce.2020.111119_bib47","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1097\/01.ASN.0000071512.93927.4E","article-title":"Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease","volume":"14","author":"Huang","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.mce.2020.111119_bib48","doi-asserted-by":"crossref","DOI":"10.1161\/circ.142.suppl_3.14387","article-title":"Dose-related reductions in blood pressure with a RNA interference (RNAi) therapeutic targeting angiotensinogen in hypertensive patients: interim results from a first-in-human phase 1 study of ALN-AGT01","volume":"142","author":"Huang","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2020.111119_bib49","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/00004872-199311000-00001","article-title":"The chymase-angiotensin system in humans","volume":"11","author":"Husain","year":"1993","journal-title":"J. Hypertens."},{"key":"10.1016\/j.mce.2020.111119_bib50","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1161\/01.RES.52.4.460","article-title":"Evidence for the existence of a family of biologically active angiotensin I-like peptides in the dog central nervous system","volume":"52","author":"Husain","year":"1983","journal-title":"Circ. Res."},{"key":"10.1016\/j.mce.2020.111119_bib51","doi-asserted-by":"crossref","first-page":"H2166","DOI":"10.1152\/ajpheart.00061.2006","article-title":"Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats","volume":"291","author":"Jessup","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.mce.2020.111119_bib52","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jash.2007.10.005","article-title":"Differential effect of low dose thiazides on the Renin Angiotensin system in genetically hypertensive and normotensive rats","volume":"2","author":"Jessup","year":"2008","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.mce.2020.111119_bib53","doi-asserted-by":"crossref","first-page":"H2614","DOI":"10.1152\/ajpheart.91521.2007","article-title":"Localization of the novel angiotensin peptide, angiotensin-(1-12), in heart and kidney of hypertensive and normotensive rats","volume":"294","author":"Jessup","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.mce.2020.111119_bib54","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1097\/00004872-199312050-00019","article-title":"M235T variant of the human angiotensinogen gene in unselected hypertensive patients","volume":"11","author":"Jeunemaitre","year":"1993","journal-title":"J. Hypertens. Suppl."},{"key":"10.1016\/j.mce.2020.111119_bib55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11906-999-0071-0","article-title":"Angiotensinogen variants and human hypertension","volume":"1","author":"Jeunemaitre","year":"1999","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.mce.2020.111119_bib56","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1124\/jpet.103.061465","article-title":"An antiarrhythmic effect of a chymase inhibitor after myocardial infarction","volume":"309","author":"Jin","year":"2004","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.mce.2020.111119_bib57","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1073\/pnas.131147598","article-title":"Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice","volume":"98","author":"Ju","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2020.111119_bib58","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/cpdd.579","article-title":"Pharmacokinetics, safety, and tolerability of the novel chymase inhibitor BAY 1142524 in healthy male volunteers","volume":"8","author":"Kanefendt","year":"2019","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.mce.2020.111119_bib59","doi-asserted-by":"crossref","first-page":"19192","DOI":"10.1016\/S0021-9258(18)54981-4","article-title":"Multiple determinants for the high substrate specificity of an angiotensin II-forming chymase from the human heart","volume":"266","author":"Kinoshita","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2020.111119_bib60","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/MNH.0b013e3282f521a8","article-title":"The intracellular renin-angiotensin system: implications in cardiovascular remodeling","volume":"17","author":"Kumar","year":"2008","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.mce.2020.111119_bib61","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-90-481-9060-7_5","article-title":"Local RAS","volume":"690","author":"Leung","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.mce.2020.111119_bib62","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijcard.2018.03.066","article-title":"Critical role of the chymase\/angiotensin-(1-12) axis in modulating cardiomyocyte contractility","volume":"264","author":"Li","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.mce.2020.111119_bib63","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijcard.2019.09.004","article-title":"Reversal of angiotensin-(1-12)-caused positive modulation on left ventricular contractile performance in heart failure: assessment by pressure-volume analysis","volume":"301","author":"Li","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.mce.2020.111119_bib64","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/ATVBAHA.115.306740","article-title":"Angiotensinogen exerts effects independent of angiotensin II","volume":"36","author":"Lu","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.mce.2020.111119_bib65","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001559","article-title":"Oxidative stress causes imbalance of renal renin angiotensin system (RAS) components and hypertension in obese Zucker rats","volume":"4","author":"Luo","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.mce.2020.111119_bib66","doi-asserted-by":"crossref","first-page":"F1328","DOI":"10.1152\/ajprenal.00337.2010","article-title":"Inhibition of chymase protects against diabetes-induced oxidative stress and renal dysfunction in hamsters","volume":"299","author":"Maeda","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.mce.2020.111119_bib67","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCRESAHA.116.303697","article-title":"Inflammation, immunity, and hypertensive end-organ damage","volume":"116","author":"McMaster","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.mce.2020.111119_bib68","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/01.ASN.0000109782.28991.26","article-title":"Chymase-like angiotensin II-generating activity in end-stage human autosomal dominant polycystic kidney disease","volume":"15","author":"McPherson","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.mce.2020.111119_bib69","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.mce.2020.111119_bib70","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11906-019-0971-6","article-title":"Adaptive immunity in hypertension","volume":"21","author":"Mikolajczyk","year":"2019","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.mce.2020.111119_bib71","doi-asserted-by":"crossref","first-page":"H644","DOI":"10.1152\/ajpheart.00210.2013","article-title":"Primacy of angiotensin converting enzyme in angiotensin-(1-12) metabolism","volume":"305","author":"Moniwa","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.mce.2020.111119_bib72","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/HYPERTENSIONAHA.117.09755","article-title":"Blood pressure lowering and safety improvements with liver angiotensinogen inhibition in models of hypertension and kidney injury","volume":"70","author":"Mullick","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2020.111119_bib73","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1074\/jbc.270.5.2218","article-title":"Human prochymase activation. A novel role for heparin in zymogen processing","volume":"270","author":"Murakami","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2020.111119_bib74","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bbrc.2006.09.146","article-title":"Isolation and identification of proangiotensin-12, a possible component of the renin-angiotensin system","volume":"350","author":"Nagata","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2020.111119_bib75","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.bbrc.2013.10.124","article-title":"Big angiotensin-25: a novel glycosylated angiotensin-related peptide isolated from human urine","volume":"441","author":"Nagata","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2020.111119_bib76","article-title":"An update on the tissue renin angiotensin system and its role in physiology and pathology","volume":"6","author":"Nehme","year":"2019","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.mce.2020.111119_bib77","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s00380-019-01352-x","article-title":"Increase of chymase-dependent angiotensin II-forming activity in circulating mononuclear leukocytes after acute myocardial infarction chymase activity after acute myocardial infarction","volume":"34","author":"Okamura","year":"2019","journal-title":"Heart Ves."},{"key":"10.1016\/j.mce.2020.111119_bib78","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1161\/CIRCULATIONAHA.109.921619","article-title":"Chymase inhibition prevents fibronectin and myofibrillar loss and improves cardiomyocyte function and LV torsion angle in dogs with isolated mitral regurgitation","volume":"122","author":"Pat","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2020.111119_bib79","doi-asserted-by":"crossref","first-page":"F1497","DOI":"10.1152\/ajprenal.00317.2005","article-title":"Differential expression of nuclear AT1 receptors and angiotensin II within the kidney of the male congenic mRen2. Lewis rat","volume":"290","author":"Pendergrass","year":"2006","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.mce.2020.111119_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e01397","article-title":"Chymase uptake by cardiomyocytes results in myosin degradation in cardiac volume overload","volume":"5","author":"Powell","year":"2019","journal-title":"Heliyon"},{"key":"10.1016\/j.mce.2020.111119_bib81","series-title":"Chymases","author":"Rao","year":"2012"},{"key":"10.1016\/j.mce.2020.111119_bib82","doi-asserted-by":"crossref","first-page":"F349","DOI":"10.1152\/ajprenal.00478.2014","article-title":"Antisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2","volume":"308","author":"Ravichandran","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.mce.2020.111119_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213096","article-title":"Circulating angiotensin peptides levels in Acute Respiratory Distress Syndrome correlate with clinical outcomes: a pilot study","volume":"14","author":"Reddy","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.mce.2020.111119_bib84","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11906-017-0708-3","article-title":"Novel cardiac intracrine mechanisms based on ang-(1-12)\/chymase Axis require a revision of therapeutic approaches in human heart disease","volume":"19","author":"Reyes","year":"2017","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.mce.2020.111119_bib85","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijcard.2019.09.052","article-title":"Angiotensin-(1-12)\/chymase axis modulates cardiomyocyte L-type calcium currents in rats expressing human angiotensinogen","volume":"297","author":"Reyes","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.mce.2020.111119_bib86","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0092-8674(93)90541-W","article-title":"Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro","volume":"75","author":"Sadoshima","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.mce.2020.111119_bib87","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1096\/fj.15-279299","article-title":"Suppressing angiotensinogen synthesis attenuates kidney cyst formation in a Pkd1 mouse model","volume":"30","author":"Saigusa","year":"2016","journal-title":"Faseb. J."},{"key":"10.1016\/j.mce.2020.111119_bib88","doi-asserted-by":"crossref","first-page":"R539","DOI":"10.1152\/ajpregu.00594.2004","article-title":"Nuclear localization of angiotensinogen in astrocytes","volume":"288","author":"Sherrod","year":"2005","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.mce.2020.111119_bib89","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/08916934.2020.1735371","article-title":"CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer","volume":"53","author":"Shi","year":"2020","journal-title":"Autoimmunity"},{"key":"10.1016\/j.mce.2020.111119_bib90","doi-asserted-by":"crossref","first-page":"H939","DOI":"10.1152\/ajpheart.00391.2007","article-title":"High-glucose-induced regulation of intracellular ANG II synthesis and nuclear redistribution in cardiac myocytes","volume":"293","author":"Singh","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.mce.2020.111119_bib91","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.2337\/db08-0805","article-title":"Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis","volume":"57","author":"Singh","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2020.111119_bib92","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.atherosclerosis.2007.06.024","article-title":"Angiotensin II AT1 receptor blockade normalizes CD11b+ monocyte production in bone marrow of hypercholesterolemic monkeys","volume":"196","author":"Strawn","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.mce.2020.111119_bib93","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2141.2004.04998.x","article-title":"Renin-angiotensin system expression in rat bone marrow haematopoietic and stromal cells","volume":"126","author":"Strawn","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mce.2020.111119_bib94","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1194\/jlr.M093252","article-title":"Angiotensinogen in hepatocytes contributes to Western diet-induced liver steatosis","volume":"60","author":"Tao","year":"2019","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.mce.2020.111119_bib95","doi-asserted-by":"crossref","first-page":"H2242","DOI":"10.1152\/ajpheart.00175.2008","article-title":"Angiotensin-(1-12) is an alternate substrate for angiotensin peptide production in the heart","volume":"294","author":"Trask","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.mce.2020.111119_bib96","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/HJH.0b013e3282f34a4a","article-title":"Renin-angiotensin system component expression in the HL-1 atrial cell line and in a pig model of atrial fibrillation","volume":"26","author":"Tsai","year":"2008","journal-title":"J. Hypertens."},{"key":"10.1016\/j.mce.2020.111119_bib97","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/HYPERTENSIONAHA.119.12703","article-title":"Strong and sustained antihypertensive effect of small interfering RNA targeting liver angiotensinogen","volume":"73","author":"Uijl","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2020.111119_bib98","doi-asserted-by":"crossref","first-page":"22348","DOI":"10.1016\/S0021-9258(18)45712-2","article-title":"Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart","volume":"265","author":"Urata","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2020.111119_bib99","doi-asserted-by":"crossref","first-page":"17173","DOI":"10.1016\/S0021-9258(19)47355-9","article-title":"Cloning of the gene and cDNA for human heart chymase","volume":"266","author":"Urata","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"Suppl. N","key":"10.1016\/j.mce.2020.111119_bib100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/eurheartj\/16.suppl_N.79","article-title":"Mechanisms of angiotensin II formation in humans","volume":"16","author":"Urata","year":"1995","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.mce.2020.111119_bib101","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/ajh\/hps090","article-title":"Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats","volume":"26","author":"Varagic","year":"2013","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.mce.2020.111119_bib102","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/FJC.0000000000000385","article-title":"Mast cell inhibition attenuates cardiac remodeling and diastolic dysfunction in middle-aged, ovariectomized fischer 344 x Brown Norway rats","volume":"68","author":"Wang","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.mce.2020.111119_bib103","doi-asserted-by":"crossref","first-page":"105744","DOI":"10.1016\/j.dib.2020.105744","article-title":"Atrial angiotensin-(1-12)\/chymase expression data in patient of heart diseases","volume":"31","author":"Wang","year":"2020","journal-title":"Data Brief"},{"key":"10.1016\/j.mce.2020.111119_bib104","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jss.2020.03.051","article-title":"Differential expression of the angiotensin-(1-12)\/chymase Axis in human atrial tissue","volume":"253","author":"Wang","year":"2020","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.mce.2020.111119_bib105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/157340212800505007","article-title":"Impact of mast cell chymase on renal disease progression","volume":"8","author":"Wasse","year":"2012","journal-title":"Curr. Hypertens. Rev."},{"key":"10.1016\/j.mce.2020.111119_bib106","doi-asserted-by":"crossref","first-page":"H784","DOI":"10.1152\/ajpheart.00793.2001","article-title":"Cardiac interstitial bradykinin and mast cells modulate pattern of LV remodeling in volume overload in rats","volume":"285","author":"Wei","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.mce.2020.111119_bib107","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.regpep.2012.03.002","article-title":"Combination of direct renin inhibition with angiotensin type 1 receptor blockade improves aldosterone but does not improve kidney injury in the transgenic Ren2 rat","volume":"176","author":"Whaley-Connell","year":"2012","journal-title":"Regul. Pept."},{"key":"10.1016\/j.mce.2020.111119_bib108","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/01.HYP.0000120963.09029.ca","article-title":"Angiotensin II and cell cycle regulation","volume":"43","author":"Wolf","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2020.111119_bib109","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.2174\/1381612811319170014","article-title":"Chymase inhibitors","volume":"19","author":"Yahiro","year":"2013","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.mce.2020.111119_bib110","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.119.13754","article-title":"Noncanonical mechanisms for direct bone marrow generating Ang II (angiotensin II) predominate in CD68 positive myeloid lineage cells","volume":"75","author":"Yamashita","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2020.111119_bib111","series-title":"Renin-Angiotensin system - considerations for hypertension and kidney","first-page":"42","volume":"6","author":"Yim","year":"2008"},{"key":"10.1016\/j.mce.2020.111119_bib112","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.116.303641","article-title":"Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal","volume":"116","author":"Zanchetti","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.mce.2020.111119_bib113","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3892\/mmr.2016.5234","article-title":"Chymase inhibition protects diabetic rats from renal lesions","volume":"14","author":"Zhang","year":"2016","journal-title":"Mol. Med. Rep."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720720304214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720720304214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:15:47Z","timestamp":1759587347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720720304214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":113,"alternative-id":["S0303720720304214"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2020.111119","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Angiotensin-(1\u201312)\/Chymase axis as an alternate component of the tissue renin angiotensin system","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2020.111119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111119"}}